Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand
Addex lost less money per share than last year, which is good. But the company made way less sales, so watch if they can grow revenue.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.